AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimatica M 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Almatica Pharmaceuticals Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimatica M 2mg/500mg Tablet ER

Metformin/Linagliptin extended-release tablets (2mg/500mg) are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan that includes dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms—sweating, dizziness, headache, tremors—and implement appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician prior to commencing treatment, as it may be unsuitable. Pregnant or lactating individuals should consult their doctor before use. Regular blood glucose monitoring is necessary, and your physician may recommend blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimatica M 2mg/500mg Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Glimatica M 2mg/500mg Tablet ER

Managing Type 2 diabetes

Major Benefits of Glimatica M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimatica M 2mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimatica M 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimatica M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimatica M 2mg/500mg Extended-Release Tablets. Ingest the tablets whole; do not crush, chew, or break them. Administer this medication with food.

How Glimatica M 2mg/500mg Tablet ER works:

Glimatica M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimatica M 2mg/500mg ER tablets with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimatica M 2mg/500mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimatica M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimatica M 2mg/500mg Extended-Release tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. In patients exhibiting severe renal insufficiency, Glimatica M 2mg/500mg Extended-Release tablets are contraindicated. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimatica M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate hepatic dysfunction, initiation should be at a low dose; however, this medication is unsuitable for those with severe liver disease.

What if you forget to take Glimatica M 2mg/500mg Tablet ER :

Should you forget a dose of Glimatica M 2mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimatica M 2mg/500mg Tablet ER

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glimatica M 2mg/500mg Tablet ER

Retain this medication within its original, sealed container. Follow the storage guidelines printed on the packaging or label. Discard any remaining medication. Prevent access by children, animals, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Glimatica M 2mg/500mg Tablet ER. This condition, also termed Metformin-associated lactic acidosis (MALA), is infrequent but poses a significant risk to individuals with compromised kidney function, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should any of these symptoms occur, discontinue Glimatica M 2mg/500mg Tablet ER use and seek immediate medical attention.
Glimatica M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used concurrently with a balanced diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin acts by decreasing hepatic glucose production and enhancing insulin responsiveness. This combination therapy is unsuitable for individuals with type 1 diabetes.
Taking Glimatica M 2mg/500mg Extended-Release Tablets may cause frequent side effects such as low blood sugar, taste changes, queasiness, abdominal discomfort, loose stools, and head pain. Rare but potentially severe adverse reactions, including lactic acidosis, are also possible. Prolonged treatment might result in Vitamin B12 insufficiency.
Prolonged use of Glimatica M 2mg/500mg Extended-Release tablets can indeed lead to Vitamin B12 deficiency. This medication impairs the stomach's absorption of Vitamin B12. Untreated deficiency may result in anemia, neurological complications such as peripheral neuropathy (tingling and numbness in extremities), weakness, urinary dysfunction, cognitive changes, and gait instability (ataxia). To mitigate these risks, supplemental Vitamin B12, administered at least annually, is recommended by some studies.
Indeed, Glimatica M 2mg/500mg Extended-Release Tablets may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic agents. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimatica M 2mg/500mg Extended-Release tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimatica M 2mg/500mg Tab...
53
MRP 64
17% off